Bergenbio ASA
OSE:BGBIO
Intrinsic Value
The intrinsic value of one BGBIO stock under the Base Case scenario is 0.2029 NOK. Compared to the current market price of 1.5642 NOK, Bergenbio ASA is Overvalued by 87%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Bergenbio ASA
Fundamental Analysis

Revenue & Expenses Breakdown
Bergenbio ASA
Balance Sheet Decomposition
Bergenbio ASA
Current Assets | 154.5m |
Cash & Short-Term Investments | 140.2m |
Receivables | 8.9m |
Other Current Assets | 5.5m |
Non-Current Assets | 1.3m |
PP&E | 1.3m |
Other Non-Current Assets | -1k |
Free Cash Flow Analysis
Bergenbio ASA
NOK | |
Free Cash Flow | NOK |
Earnings Waterfall
Bergenbio ASA
Revenue
|
848k
NOK
|
Operating Expenses
|
-152.1m
NOK
|
Operating Income
|
-151.2m
NOK
|
Other Expenses
|
12m
NOK
|
Net Income
|
-139.3m
NOK
|
BGBIO Profitability Score
Profitability Due Diligence
Bergenbio ASA's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Bergenbio ASA's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
BGBIO Solvency Score
Solvency Due Diligence
Bergenbio ASA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Score
Bergenbio ASA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BGBIO Price Targets Summary
Bergenbio ASA
According to Wall Street analysts, the average 1-year price target for BGBIO is 5.1 NOK with a low forecast of 5.05 NOK and a high forecast of 5.25 NOK.
Dividends
Current shareholder yield for BGBIO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one BGBIO stock under the Base Case scenario is 0.2029 NOK.
Compared to the current market price of 1.5642 NOK, Bergenbio ASA is Overvalued by 87%.